{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:48:43Z","timestamp":1783993723133,"version":"3.55.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["ROUILL22F0"],"award-info":[{"award-number":["ROUILL22F0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HILL19G0"],"award-info":[{"award-number":["HILL19G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HILL20Y2-OUT"],"award-info":[{"award-number":["HILL20Y2-OUT"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BOUCHE19R0"],"award-info":[{"award-number":["BOUCHE19R0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1P01HL164320"],"award-info":[{"award-number":["1P01HL164320"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK065988"],"award-info":[{"award-number":["P30DK065988"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>People with muco-obstructive pulmonary diseases such as cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) often have acute or chronic respiratory infections that are difficult to treat due in part to the accumulation of hyperconcentrated mucus within the airway. Mucus accumulation and obstruction promote chronic inflammation and infection and reduce therapeutic efficacy. Bacterial aggregates in the form of biofilms exhibit increased resistance to mechanical stressors from the immune response (e.g., phagocytosis) and chemical treatments including antibiotics. Herein, combination treatments designed to disrupt the mechanical properties of biofilms and potentiate antibiotic efficacy are investigated against mucus-grown <jats:italic>Pseudomonas aeruginosa<\/jats:italic> biofilms and optimized to 1) alter biofilm viscoelastic properties, 2) increase mucociliary transport rates, and 3) reduce bacterial viability. A disulfide bond reducing agent (tris(2-carboxyethyl)phosphine, TCEP), a surfactant (NP40), a biopolymer (hyaluronic acid, HA), a DNA degradation enzyme (DNase), and an antibiotic (tobramycin) are tested in various combinations to maximize biofilm disruption. The viscoelastic properties of biofilms are quantified with particle tracking microrheology and transport rates are quantified in a mucociliary transport device comprised of fully differentiated primary human bronchial epithelial cells. The combination of the NP40 with hyaluronic acid and tobramycin was the most effective at increasing mucociliary transport rates, decreasing the viscoelastic properties of mucus, and reducing bacterial viability. Multimechanistic targeting of biofilm infections may ultimately result in improved clinical outcomes, and the results of this study may be translated into future in vivo infection models.<\/jats:p>","DOI":"10.1371\/journal.pone.0294120","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:57:31Z","timestamp":1708714651000},"page":"e0294120","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combination treatment to improve mucociliary transport of Pseudomonas aeruginosa biofilms"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0856-8640","authenticated-orcid":true,"given":"Kaitlyn R.","family":"Rouillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7703-8779","authenticated-orcid":true,"given":"Christopher P.","family":"Esther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Kissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas M.","family":"Plott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean W.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Markovetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"pone.0294120.ref001","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/physrev.00004.2021","article-title":"Physiology and pathophysiology of human airway mucus","volume":"102","author":"DB Hill","year":"2022","journal-title":"Physiol Rev"},{"key":"pone.0294120.ref002","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/COPD.S346294","article-title":"Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis.","volume":"17","author":"MA Martinez-Garc\u00eda","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"pone.0294120.ref003","first-page":"32","article-title":"Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface.","author":"S Malhotra","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"pone.0294120.ref004","doi-asserted-by":"crossref","first-page":"1801297","DOI":"10.1183\/13993003.01297-2018","article-title":"Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH","volume":"52","author":"DB Hill","year":"2018","journal-title":"European Respiratory Journal"},{"key":"pone.0294120.ref005","doi-asserted-by":"crossref","first-page":"e87681","DOI":"10.1371\/journal.pone.0087681","article-title":"A Biophysical Basis for Mucus Solids Concentration as a Candidate Biomarker for Airways Disease","volume":"9","author":"DB Hill","year":"2014","journal-title":"PLoS One"},{"key":"pone.0294120.ref006","first-page":"118","article-title":"Assembly and organization of the N-terminal region of mucin MUC5AC: Indications for structural and functional distinction from MUC5B","author":"J Carpenter","year":"2021","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"pone.0294120.ref007","doi-asserted-by":"crossref","first-page":"eabq5049","DOI":"10.1126\/sciadv.abq5049","article-title":"MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium.","volume":"8","author":"D Song","year":"2022","journal-title":"Sci Adv."},{"key":"pone.0294120.ref008","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/bj3610537","article-title":"Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B","volume":"361","author":"S KIRKHAM","year":"2002","journal-title":"Biochemical Journal"},{"key":"pone.0294120.ref009","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.bpj.2021.01.041","article-title":"Induction of ciliary orientation by matrix patterning and characterization of mucociliary transport","volume":"120","author":"PR Sears","year":"2021","journal-title":"Biophys J"},{"key":"pone.0294120.ref010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.chest.2018.03.005","article-title":"Cystic Fibrosis Sputum Rheology Correlates With Both Acute and Longitudinal Changes in Lung Function.","volume":"154","author":"JT Ma","year":"2018","journal-title":"Chest"},{"key":"pone.0294120.ref011","doi-asserted-by":"crossref","first-page":"100080","DOI":"10.1016\/j.bioflm.2022.100080","article-title":"Prevalence of biofilms in acute infections challenges a longstanding paradigm.","volume":"4","author":"M Kolpen","year":"2022","journal-title":"Biofilm"},{"key":"pone.0294120.ref012","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/thoraxjnl-2021-217576","article-title":"Bacterial biofilms predominate in both acute and chronic human lung infections","volume":"77","author":"M Kolpen","year":"2022","journal-title":"Thorax"},{"key":"pone.0294120.ref013","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jpeds.2014.02.010","article-title":"Impaired mucociliary clearance in cystic fibrosis and P aeruginosa","volume":"164","author":"RW Wilmott","year":"2014","journal-title":"J Pediatr"},{"key":"pone.0294120.ref014","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.tim.2020.03.016","article-title":"Biofilm Matrixome: Extracellular Components in Structured Microbial Communities","volume":"28","author":"L Karygianni","year":"2020","journal-title":"Trends Microbiol"},{"key":"pone.0294120.ref015","first-page":"373","article-title":"Spatial transcriptomics of planktonic and sessile bacterial populations at single-cell resolution","author":"D Dar","year":"2021","journal-title":"Science (1979)."},{"key":"pone.0294120.ref016","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1039\/c0sm01467b","article-title":"Mechanical robustness of Pseudomonas aeruginosa biofilms","volume":"7","author":"O Lieleg","year":"2011","journal-title":"Soft Matter"},{"key":"pone.0294120.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41522-016-0007-9","article-title":"Evolutionary adaptations of biofilms infecting cystic fibrosis lungs promote mechanical toughness by adjusting polysaccharide production","volume":"3","author":"K Kovach","year":"2017","journal-title":"NPJ Biofilms Microbiomes"},{"key":"pone.0294120.ref018","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tim.2016.01.008","article-title":"Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections","volume":"24","author":"C Winstanley","year":"2016","journal-title":"Trends Microbiol"},{"key":"pone.0294120.ref019","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00430-020-00691-1","article-title":"Bacterial aggregate size determines phagocytosis efficiency of polymorphonuclear leukocytes","volume":"209","author":"M Alhede","year":"2020","journal-title":"Med Microbiol Immunol"},{"key":"pone.0294120.ref020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/femsre\/fuu008","article-title":"Viscoelasticity of biofilms and their recalcitrance to mechanical and chemical challenges","volume":"39","author":"BW Peterson","year":"2015","journal-title":"FEMS Microbiol Rev"},{"key":"pone.0294120.ref021","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/acsinfecdis.0c00246","article-title":"Pseudomonas aeruginosa Biofilm Eradication via Nitric Oxide-Releasing Cyclodextrins.","volume":"6","author":"KR Rouillard","year":"2020","journal-title":"ACS Infect Dis"},{"key":"pone.0294120.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01972-18","article-title":"Role of viscoelasticity in bacterial killing by antimicrobials in differently grown P. aeruginosa biofilms","volume":"63","author":"RT Rozenbaum","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0294120.ref023","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/jamp.2011.0942","article-title":"Sputum tobramycin concentrations in cystic fibrosis patients with repeated administration of inhaled tobramycin","volume":"26","author":"J Ruddy","year":"2013","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"pone.0294120.ref024","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1093\/jac\/dky241","article-title":"Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin","volume":"73","author":"L M\u00fcller","year":"2018","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"pone.0294120.ref025","doi-asserted-by":"crossref","first-page":"100104","DOI":"10.1016\/j.bioflm.2023.100104","article-title":"Altering the viscoelastic properties of mucus-grown Pseudomonas aeruginosa biofilms affects antibiotic susceptibility","author":"KR Rouillard","year":"2023","journal-title":"Biofilm"},{"key":"pone.0294120.ref026","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.00471-08","article-title":"Effect of DNase and antibiotics on biofilm characteristics","volume":"53","author":"GV Tetz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0294120.ref027","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/AAC.01721-15","article-title":"OligoG CF-5\/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model","volume":"60","author":"W Hengzhuang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0294120.ref028","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jcf.2022.01.003","article-title":"Evaluating the alginate oligosaccharide (OligoG) as a therapy for Burkholderia cepacia complex cystic fibrosis lung infection","volume":"21","author":"R Fischer","year":"2022","journal-title":"J Cyst Fibros"},{"key":"pone.0294120.ref029","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1128\/AAC.00525-12","article-title":"Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics","volume":"56","author":"S Khan","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0294120.ref030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41522-018-0056-3","article-title":"Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides","volume":"4","author":"LC Powell","year":"2018","journal-title":"NPJ Biofilms Microbiomes"},{"key":"pone.0294120.ref031","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/08927014.2013.777954","article-title":"The effect of alginate oligosaccharides on the mechanical properties of Gram-negative biofilms.","volume":"29","author":"LC Powell","year":"2013","journal-title":"Biofouling"},{"key":"pone.0294120.ref032","doi-asserted-by":"crossref","first-page":"e0029122","DOI":"10.1128\/msphere.00291-22","article-title":"Effects of Mucin and DNA Concentrations in Airway Mucus on Pseudomonas aeruginosa Biofilm Recalcitrance.","volume":"7","author":"KR Rouillard","year":"2022","journal-title":"mSphere"},{"key":"pone.0294120.ref033","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2011.08.032","article-title":"A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles.","volume":"157","author":"O Mert","year":"2012","journal-title":"J Control Release"},{"key":"pone.0294120.ref034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2500\/ajra.2011.25.3583","article-title":"The effect of dilute baby shampoo on nasal mucociliary clearance in healthy subjects","volume":"25","author":"S Isaacs","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"pone.0294120.ref035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1164\/rccm.201802-0245OC","article-title":"An improved inhaled mucolytic to treat airway muco-obstructive diseases","volume":"199","author":"C Ehre","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0294120.ref036","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2015.04.028","article-title":"Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections","volume":"209","author":"A Baelo","year":"2015","journal-title":"Journal of Controlled Release"},{"key":"pone.0294120.ref037","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1021\/acs.langmuir.9b02188","article-title":"Specific Disruption of Established Pseudomonas aeruginosa Biofilms Using Polymer-Attacking Enzymes.","volume":"36","author":"KN Kovach","year":"2020","journal-title":"Langmuir"},{"key":"pone.0294120.ref038","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1021\/acsbiomaterials.2c00392","article-title":"Role of Nitric Oxide-Releasing Glycosaminoglycans in Wound Healing.","volume":"8","author":"SE Maloney","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"pone.0294120.ref039","doi-asserted-by":"crossref","first-page":"L498","DOI":"10.1152\/ajplung.00238.2019","article-title":"Endotracheal tube mucus as a source of airway mucus for rheological study","volume":"317","author":"MR Markovetz","year":"2019","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"pone.0294120.ref040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/1040841X.2021.1962802","article-title":"Water in bacterial biofilms: pores and channels, storage and transport functions","volume":"48","author":"K Quan","year":"2022","journal-title":"Crit Rev Microbiol"},{"key":"pone.0294120.ref041","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1021\/acs.biomac.7b00809","article-title":"A Rheological Study of the Association and Dynamics of MUC5AC Gels.","volume":"18","author":"CE Wagner","year":"2017","journal-title":"Biomacromolecules"},{"key":"pone.0294120.ref042","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/thx.40.2.125","article-title":"Effect of bacterial products on human ciliary function in vitro.","volume":"40","author":"R Wilson","year":"1985","journal-title":"Thorax"},{"key":"pone.0294120.ref043","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1086\/656788","article-title":"Colistin\u2010Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of Biofilm Pseudomonas aeruginosa","volume":"202","author":"G Herrmann","year":"2010","journal-title":"J Infect Dis"},{"key":"pone.0294120.ref044","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acsinfecdis.0c00337","article-title":"Exogenous Nitric Oxide Improves Antibiotic Susceptibility in Resistant Bacteria.","volume":"7","author":"KR Rouillard","year":"2021","journal-title":"ACS Infect Dis"},{"key":"pone.0294120.ref045","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10096-013-1876-y","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.","volume":"32","author":"MC Gaspar","year":"2013","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0294120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:58:03Z","timestamp":1708714683000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0294120"}},"subtitle":[],"editor":[{"given":"Abdelwahab","family":"Omri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0294120","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}